Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Barinthus Biotherapeutics (BRNS) Short-term Investments (2024 - 2025)

Historic Short-term Investments for Barinthus Biotherapeutics (BRNS) over the last 2 years, with Q3 2025 value amounting to $1.4 million.

  • Barinthus Biotherapeutics' Short-term Investments changed N/A to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year change of. This contributed to the annual value of $1.7 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Barinthus Biotherapeutics' Short-term Investments is $1.4 million.
  • Over the past 5 years, Barinthus Biotherapeutics' Short-term Investments peaked at $1.7 million during Q4 2024, and registered a low of $1.4 million during Q3 2025.